Darwin Americas Health Care

Niagen Bioscience Inc (Score +6)

Fri Oct 17 10:51:33 UTC 2025

US Stocks: Niagen Bioscience Inc has an overall darwin score of +6 and there are 3 alerts.

The score is composed from the following sections:

• +6 Price
• 0 Sentiment
• +3 Fundamentals
• 0 Flow
• -3 Models

Share    

Johnson & Johnson (Score +27)

Fri Oct 17 10:51:30 UTC 2025

US Large Caps: Johnson & Johnson has an overall darwin score of +27 and there are 16 alerts.

The score is composed from the following sections:

• +29 Price
• 0 Sentiment
• +3 Fundamentals
• -1 Flow
• -4 Models

Share    

Catalyst Pharmaceuticals Inc (Overall - Favourable)

Fri Oct 17 10:51:02 UTC 2025

Catalyst Pharmaceuticals Inc has the best Models score in North America. The models score is +41. Catalyst Pharmaceuticals Inc has a total score of +50 and there are 8 alerts.

The overall rating for Catalyst Pharmaceuticals Inc is favorable, based on a comprehensive analysis of its health, valuation, price, and models ratings. The company exhibits strong operational efficiency and profitability, with healthy margins and returns on equity and assets. Valuation metrics indicate that the stock is fairly valued compared to its peers, suggesting potential for growth. While the price analysis shows a neutral sentiment due to overbought conditions, the positive models rating indicates a strong likelihood of price increases in the near future. Additionally, the upcoming earnings report scheduled for November 5, 2025, may serve as a catalyst for movement, providing an opportunity for investors to reassess the stock's value. Overall, the combination of strong fundamentals, fair valuation, and positive model forecasts supports a favorable outlook for Catalyst Pharmaceuticals Inc.

Share    

Leaders by 1 Day Performance

Fri Oct 17 09:41:02 UTC 2025

Asset Name	Perf(1d)%	Asset Score
TNF Pharmaceuticals Inc (TNFA)	48.1	+9
ReShape Lifesciences Inc (RSLS)	22.5	-8
Delcath Systems Inc (DCTH)	9.2	+33
Xencor Inc (XNCR)	6.0	+3
Certara Inc (CERT)	5.8	+3
Medicus Pharma Ltd (MDCX)	5.2	+12
Avantor Inc (AVTR)	5.0	+14
Progyny Inc (PGNY)	5.0	+4
Mesa Laboratories Inc (MLAB)	4.8	+9
PMGC Holdings Inc (ELAB)	4.6	+13
Owens & Minor Inc (OMI)	4.3	-8
Astrana Health Inc (ASTH)	4.3	+15
Mettler-Toledo International Inc (MTD)	4.3	+18
Cooper Companies Inc (COO)	4.1	+29
QuidelOrtho Corp (QDEL)	4.1	+7
Tandem Diabetes Care Inc (TNDM)	3.7	+9
Corcept Therapeutics Inc (CORT)	3.5	+19
Vericel Corp (VCEL)	3.5	-5
Bio-Techne Corp (TECH)	3.4	+14
Repligen Corp (RGEN)	3.4	+27
Illumina Inc (ILMN)	3.1	0
Neogenomics Inc (NEO)	3.1	+8
Carisma Therapeutics Inc (CARM)	2.9	-18
Vaxart Inc (VXRT)	2.9	-10
Transmedics Group Inc (TMDX)	2.7	+27
Simulations Plus Inc (SLP)	2.7	+5
Integra Lifesciences Holdings Corp (IART)	2.7	+14
Charles River Laboratories International Inc (CRL)	2.5	+6
Danaher Corp (DHR)	2.3	+34
Hologic Inc (HOLX)	2.2	+27
ANI Pharmaceuticals Inc (ANIP)	2.1	+41
Arrowhead Pharmaceuticals Inc (ARWR)	2.0	+20
Revvity Inc (RVTY)	2.0	+13
Teleflex Inc (TFX)	2.0	+1
Humana Inc (HUM)	1.9	+18
Thermo Fisher Scientific Inc (TMO)	1.7	+30
West Pharmaceutical Services Inc (WST)	1.6	+31
Prestige Consumer Healthcare Inc (PBH)	1.4	-4
Dexcom Inc (DXCM)	1.4	+1
Medpace Holdings Inc (MEDP)	1.3	+33
Avanos Medical Inc (AVNS)	1.3	-1
IQVIA Holdings Inc (IQV)	1.3	+30
Omnicell Inc (OMCL)	1.3	+1
Insulet Corp (PODD)	1.2	+16
Viatris Inc (VTRS)	1.2	+19
Privia Health Group Inc (PRVA)	1.1	+10
Align Technology Inc (ALGN)	1.1	-1

Share    

Catalyst Pharmaceuticals Inc (Overall - Favourable)

Fri Oct 17 09:34:29 UTC 2025

Catalyst Pharmaceuticals Inc has the best Models score in North America. The models score is +41. Catalyst Pharmaceuticals Inc has a total darwin score of +50 and there are 8 alerts.

The overall rating for Catalyst Pharmaceuticals Inc is favorable, based on a comprehensive analysis of its health, valuation, price, and models ratings. The company exhibits strong operational efficiency and profitability, with healthy margins and returns on equity and assets. Valuation metrics indicate that the stock is fairly valued compared to its peers, suggesting potential for growth. While the price analysis shows a neutral sentiment due to overbought conditions, the positive models rating indicates a strong likelihood of price increases in the near future. Additionally, the upcoming earnings report scheduled for November 5, 2025, may serve as a catalyst for movement, providing an opportunity for investors to reassess the stock's value. Overall, the combination of strong fundamentals, fair valuation, and positive model forecasts supports a favorable outlook for Catalyst Pharmaceuticals Inc.

Share    

Relative Scores

Fri Oct 17 08:17:18 UTC 2025

The average score across these 189 assets is 6.7.

Share    

Catalyst Pharmaceuticals Inc (Overall - Favourable)

Fri Oct 17 08:13:02 UTC 2025

Catalyst Pharmaceuticals Inc has the best Models score in North America. The models score is +41. Catalyst Pharmaceuticals Inc has an overall darwin score of +50 and there are 8 alerts.

The overall rating for Catalyst Pharmaceuticals Inc is favorable, based on a comprehensive analysis of its health, valuation, price, and models ratings. The company exhibits strong operational efficiency and profitability, with healthy margins and returns on equity and assets. Valuation metrics indicate that the stock is fairly valued compared to its peers, suggesting potential for growth. While the price analysis shows a neutral sentiment due to overbought conditions, the positive models rating indicates a strong likelihood of price increases in the near future. Additionally, the upcoming earnings report scheduled for November 5, 2025, may serve as a catalyst for movement, providing an opportunity for investors to reassess the stock's value. Overall, the combination of strong fundamentals, fair valuation, and positive model forecasts supports a favorable outlook for Catalyst Pharmaceuticals Inc.

Share    

Candle Patterns (Price Sentiment)

Fri Oct 17 07:04:23 UTC 2025

Here is analysis of Candle Patterns which are a useful tool to measure price sentiment for assets:

Share    

Catalyst Pharmaceuticals Inc (Overall - Favourable)

Fri Oct 17 06:57:27 UTC 2025

Catalyst Pharmaceuticals Inc has the best Models score in North America. The models score is +41. Catalyst Pharmaceuticals Inc has an overall score of +50 and there are 8 alerts.

The overall rating for Catalyst Pharmaceuticals Inc is favorable, based on a comprehensive analysis of its health, valuation, price, and models ratings. The company exhibits strong operational efficiency and profitability, with healthy margins and returns on equity and assets. Valuation metrics indicate that the stock is fairly valued compared to its peers, suggesting potential for growth. While the price analysis shows a neutral sentiment due to overbought conditions, the positive models rating indicates a strong likelihood of price increases in the near future. Additionally, the upcoming earnings report scheduled for November 5, 2025, may serve as a catalyst for movement, providing an opportunity for investors to reassess the stock's value. Overall, the combination of strong fundamentals, fair valuation, and positive model forecasts supports a favorable outlook for Catalyst Pharmaceuticals Inc.

Share    

Analytical Models

Fri Oct 17 05:46:41 UTC 2025

Here is a Model Score report:

Share    

Catalyst Pharmaceuticals Inc (Overall - Favourable)

Fri Oct 17 05:41:51 UTC 2025

Catalyst Pharmaceuticals Inc has the best Models score in North America. The models score is +41. Catalyst Pharmaceuticals Inc has a total score of +50 and there are 8 alerts.

The overall rating for Catalyst Pharmaceuticals Inc is favorable, based on a comprehensive analysis of its health, valuation, price, and models ratings. The company exhibits strong operational efficiency and profitability, with healthy margins and returns on equity and assets. Valuation metrics indicate that the stock is fairly valued compared to its peers, suggesting potential for growth. While the price analysis shows a neutral sentiment due to overbought conditions, the positive models rating indicates a strong likelihood of price increases in the near future. Additionally, the upcoming earnings report scheduled for November 5, 2025, may serve as a catalyst for movement, providing an opportunity for investors to reassess the stock's value. Overall, the combination of strong fundamentals, fair valuation, and positive model forecasts supports a favorable outlook for Catalyst Pharmaceuticals Inc.

Share    

High Activity Screen

Fri Oct 17 04:28:20 UTC 2025

Here is a list of assets moving up or down on unusually high volume.

Share    

Catalyst Pharmaceuticals Inc (Overall - Favourable)

Fri Oct 17 04:22:26 UTC 2025

Catalyst Pharmaceuticals Inc has the best Models score in North America. The models score is +41. Catalyst Pharmaceuticals Inc has a total score of +50 and there are 8 alerts.

The overall rating for Catalyst Pharmaceuticals Inc is favorable, based on a comprehensive analysis of its health, valuation, price, and models ratings. The company exhibits strong operational efficiency and profitability, with healthy margins and returns on equity and assets. Valuation metrics indicate that the stock is fairly valued compared to its peers, suggesting potential for growth. While the price analysis shows a neutral sentiment due to overbought conditions, the positive models rating indicates a strong likelihood of price increases in the near future. Additionally, the upcoming earnings report scheduled for November 5, 2025, may serve as a catalyst for movement, providing an opportunity for investors to reassess the stock's value. Overall, the combination of strong fundamentals, fair valuation, and positive model forecasts supports a favorable outlook for Catalyst Pharmaceuticals Inc.

Share    

Market Cycle Analysis

Fri Oct 17 03:10:02 UTC 2025

The median 1m Return(%) is 0.3 and the median 12m Return(%) is -11.6. The analysis of the relative performance of these assets is as follows in the table below:

Share    

Catalyst Pharmaceuticals Inc (Overall - Favourable)

Fri Oct 17 03:07:28 UTC 2025

Catalyst Pharmaceuticals Inc has the best Models score in North America. The models score is +41. Catalyst Pharmaceuticals Inc has a total score of +50 and there are 8 alerts.

The overall rating for Catalyst Pharmaceuticals Inc is favorable, based on a comprehensive analysis of its health, valuation, price, and models ratings. The company exhibits strong operational efficiency and profitability, with healthy margins and returns on equity and assets. Valuation metrics indicate that the stock is fairly valued compared to its peers, suggesting potential for growth. While the price analysis shows a neutral sentiment due to overbought conditions, the positive models rating indicates a strong likelihood of price increases in the near future. Additionally, the upcoming earnings report scheduled for November 5, 2025, may serve as a catalyst for movement, providing an opportunity for investors to reassess the stock's value. Overall, the combination of strong fundamentals, fair valuation, and positive model forecasts supports a favorable outlook for Catalyst Pharmaceuticals Inc.

Share    

Asset Analysis

Fri Oct 17 01:52:46 UTC 2025

Here are the analyser results for these 189 assets.

Share    

Catalyst Pharmaceuticals Inc (Overall - Favourable)

Fri Oct 17 01:42:32 UTC 2025

Catalyst Pharmaceuticals Inc has the best Models score in North America. The models score is +41. Catalyst Pharmaceuticals Inc has an overall darwin score of +50 and there are 8 alerts.

The overall rating for Catalyst Pharmaceuticals Inc is favorable, based on a comprehensive analysis of its health, valuation, price, and models ratings. The company exhibits strong operational efficiency and profitability, with healthy margins and returns on equity and assets. Valuation metrics indicate that the stock is fairly valued compared to its peers, suggesting potential for growth. While the price analysis shows a neutral sentiment due to overbought conditions, the positive models rating indicates a strong likelihood of price increases in the near future. Additionally, the upcoming earnings report scheduled for November 5, 2025, may serve as a catalyst for movement, providing an opportunity for investors to reassess the stock's value. Overall, the combination of strong fundamentals, fair valuation, and positive model forecasts supports a favorable outlook for Catalyst Pharmaceuticals Inc.

Share    

Alerts

Fri Oct 17 00:29:19 UTC 2025

agilon health inc - 5 alerts

• Oversold - The 15 week RSI is +29.6. (Bullish)
• Oversold - The 5 month RSI is +11.6. (Bullish)
• Oversold - The 15 month RSI is +27.0. (Bullish)
• ... plus another 2 alerts

Bioventus Inc - 4 alerts

• Overbought - The 5 day RSI is +81.7. (Bearish)
• Cross Over (Up):20dma . (Bullish) This alert has occurred 12 times over the last last year. The average forward returns are 0.0% over 5 days, 0.4% over 10 days, -1.6% over 15 days and -5.9% over 20 days.
• Volatility Squeeze:BB Width Narrowing (mt). (Bullish) This alert has occurred 30 times over the last last year. The average forward returns are -1.6% over 5 days, -1.6% over 10 days, -3.4% over 15 days and -3.4% over 20 days.
• ... plus another 1 alerts

Resmed Inc - 2 alerts

• Oversold - The 5 day RSI is +17.1. (Bullish)
• 5d RSI Oversold. (Bearish) This alert has occurred 42 times over the last last year. The average forward returns are 1.5% over 5 days, 1.7% over 10 days, 2.8% over 15 days and 2.6% over 20 days.

Prestige Consumer Healthcare Inc - 10 alerts

• Oversold - The 5 day RSI is +23.5. (Bullish)
• Oversold - The 5 week RSI is +4.7. (Bullish)
• Oversold - The 15 week RSI is +15.2. (Bullish)
• ... plus another 7 alerts

Humana Inc - 2 alerts

• Oversold - The 5 day RSI is +16.5. (Bullish)
• 5d RSI Oversold. (Bearish) This alert has occurred 60 times over the last last year. The average forward returns are 0.4% over 5 days, 0.0% over 10 days, 2.1% over 15 days and 3.4% over 20 days.

DENTSPLY SIRONA Inc - 9 alerts

• Overbought - The 5 day RSI is +77.2. (Bearish)
• Oversold - The 5 month RSI is +20.4. (Bullish)
• Oversold - The 15 month RSI is +25.8. (Bullish)
• ... plus another 6 alerts

Vertex Pharmaceuticals Inc - 1 alert

• Candle Pattern :: Inverted Hammer (Bearish) (Negative) (Bearish)

Regeneron Pharmaceuticals Inc - 3 alerts

• Volatility Squeeze:BB Width Narrowing (mt). (Bullish) This alert has occurred 30 times over the last last year. The average forward returns are -3.3% over 5 days, -4.2% over 10 days, -4.8% over 15 days and -6.2% over 20 days.
• Cross Over (Up):50dma . (Bullish) This alert has occurred 10 times over the last last year. The average forward returns are -4.5% over 5 days, -4.8% over 10 days, -5.6% over 15 days and -6.2% over 20 days.
• Volatility Squeeze:BB Width Narrowing (st). (Bullish) This alert has occurred 44 times over the last last year. The average forward returns are 0.8% over 5 days, -0.4% over 10 days, -1.6% over 15 days and -2.1% over 20 days.
• ... plus another 0 alerts

Intuitive Surgical Inc - 2 alerts

• Oversold - The 5 month RSI is +13.2. (Bullish)
• Volatility Squeeze:BB Width Narrowing (st). (Bullish) This alert has occurred 44 times over the last last year. The average forward returns are -1.3% over 5 days, -2.8% over 10 days, -2.5% over 15 days and -1.7% over 20 days.

Incyte Corp - 12 alerts

• Overbought - The 5 day RSI is +84.0. (Bearish)
• Overbought - The 5 week RSI is +74.6. (Bearish)
• Overbought - The 15 week RSI is +73.8. (Bearish)
• ... plus another 9 alerts

Henry Schein Inc - 7 alerts

• Oversold - The 5 day RSI is +26.9. (Bullish)
• Oversold - The 15 day RSI is +29.5. (Bullish)
• Oversold - The 5 week RSI is +8.7. (Bullish)
• ... plus another 4 alerts

Gilead Sciences Inc - 7 alerts

• Overbought - The 5 day RSI is +72.6. (Bearish)
• Overbought - The 5 week RSI is +74.0. (Bearish)
• Overbought - The 5 month RSI is +76.4. (Bearish)
• ... plus another 4 alerts

BioMarin Pharmaceutical Inc - 3 alerts

• Oversold - The 5 week RSI is +21.8. (Bullish)
• Oversold - The 5 month RSI is +23.2. (Bullish)
• Cross Over (Up):5dma . (Bullish) This alert has occurred 34 times over the last last year. The average forward returns are -0.5% over 5 days, -2.1% over 10 days, -2.9% over 15 days and -3.0% over 20 days.
• ... plus another 0 alerts

Biogen Inc - 3 alerts

• Oversold - The 5 day RSI is +17.2. (Bullish)
• Overbought - The 5 month RSI is +70.8. (Bearish)
• 5d RSI Oversold. (Bearish) This alert has occurred 72 times over the last last year. The average forward returns are -0.7% over 5 days, -0.6% over 10 days, -1.4% over 15 days and -3.6% over 20 days.
• ... plus another 0 alerts

Amgen Inc - 4 alerts

• Overbought - The 5 day RSI is +75.6. (Bearish)
• Overbought - The 5 week RSI is +71.4. (Bearish)
• Candle Pattern :: Inverted Hammer (Bearish) (Negative) (Bearish)
• ... plus another 1 alerts

Charles River Laboratories International Inc - 2 alerts

• Overbought - The 5 month RSI is +71.2. (Bearish)
• Cross Over (Up):5dma . (Bullish) This alert has occurred 30 times over the last last year. The average forward returns are 0.7% over 5 days, 0.3% over 10 days, 0.9% over 15 days and 2.3% over 20 days.

Concentra Group Holdings Parent Inc - 2 alerts

• Oversold - The 5 week RSI is +19.4. (Bullish)
• Volatility Squeeze:BB Width Narrowing (st). (Bullish) This alert has occurred 30 times over the last last year. The average forward returns are 0.3% over 5 days, 1.5% over 10 days, 2.2% over 15 days and 2.3% over 20 days.

Bio-Techne Corp - 3 alerts

• Overbought - The 5 week RSI is +72.2. (Bearish)
• Overbought - The 5 month RSI is +71.3. (Bearish)
• Cross Over (Up):5dma . (Bullish) This alert has occurred 35 times over the last last year. The average forward returns are -0.3% over 5 days, -0.6% over 10 days, -1.4% over 15 days and -0.9% over 20 days.
• ... plus another 0 alerts

Emergent BioSolutions Inc - 3 alerts

• Overbought - The 5 week RSI is +71.5. (Bearish)
• Overbought - The 5 month RSI is +71.9. (Bearish)
• Cross Over (Up):5dma . (Bullish) This alert has occurred 29 times over the last last year. The average forward returns are 0.5% over 5 days, 0.3% over 10 days, 0.2% over 15 days and 3.4% over 20 days.
• ... plus another 0 alerts

Sotera Health Co - 4 alerts

• Overbought - The 5 day RSI is +75.9. (Bearish)
• Overbought - The 5 month RSI is +85.2. (Bearish)
• 5d RSI Overbought. (Bullish) This alert has occurred 59 times over the last last year. The average forward returns are 0.8% over 5 days, 0.6% over 10 days, 1.2% over 15 days and 0.6% over 20 days.
• ... plus another 1 alerts

Tempus AI Inc - 2 alerts

• Overbought - The 5 month RSI is +90.8. (Bearish)
• Overbought - The 15 month RSI is +73.8. (Bearish)

Principal Technologies Inc - 3 alerts

• Oversold - The 5 day RSI is +13.9. (Bullish)
• Overbought - The 15 month RSI is +70.3. (Bearish)
• 5d RSI Oversold. (Bearish) This alert has occurred 50 times over the last last year. The average forward returns are 7.6% over 5 days, 13.5% over 10 days, 15.1% over 15 days and 13.4% over 20 days.
• ... plus another 0 alerts

Bristol-Myers Squibb Co - 4 alerts

• Oversold - The 5 day RSI is +27.3. (Bullish)
• Oversold - The 5 month RSI is +16.4. (Bullish)
• 5d RSI Oversold. (Bearish) This alert has occurred 62 times over the last last year. The average forward returns are -0.3% over 5 days, 0.4% over 10 days, 0.6% over 15 days and -0.4% over 20 days.
• ... plus another 1 alerts

FibroGen Inc - 3 alerts

• Overbought - The 5 month RSI is +70.4. (Bearish)
• Volatility Squeeze:BB Width Narrowing (mt). (Bullish) This alert has occurred 20 times over the last last year. The average forward returns are 5.2% over 5 days, 15.9% over 10 days, 14.6% over 15 days and 24.4% over 20 days.
• Cross Over (Down):50dma . (Bearish) This alert has occurred 11 times over the last last year. The average forward returns are -0.3% over 5 days, 11.0% over 10 days, 9.5% over 15 days and 12.4% over 20 days.
• ... plus another 0 alerts

Johnson & Johnson - 16 alerts

• Overbought - The 5 day RSI is +85.6. (Bearish)
• Overbought - The 15 day RSI is +82.5. (Bearish)
• Overbought - The 30 day RSI is +76.0. (Bearish)
• ... plus another 13 alerts

AbbVie Inc - 6 alerts

• Oversold - The 5 day RSI is +18.0. (Bullish)
• Overbought - The 5 month RSI is +93.4. (Bearish)
• Overbought - The 15 month RSI is +77.7. (Bearish)
• ... plus another 3 alerts

UnitedHealth Group Inc - 1 alert

• Cross Over (Up):5dma . (Bullish) This alert has occurred 29 times over the last last year. The average forward returns are 0.5% over 5 days, -0.3% over 10 days, -1.1% over 15 days and -0.2% over 20 days.

Abbott Laboratories - 11 alerts

• Volume is 2.3x 20 day average. (Bearish)
• Oversold - The 5 day RSI is +24.1. (Bullish)
• Oversold - The 5 week RSI is +25.1. (Bullish)
• ... plus another 8 alerts

Merck & Co Inc - 4 alerts

• Price is at a 5d low. (Bearish)
• Oversold - The 5 day RSI is +15.4. (Bullish)
• 5d RSI Oversold. (Bearish) This alert has occurred 75 times over the last last year. The average forward returns are -0.4% over 5 days, -0.6% over 10 days, -0.3% over 15 days and -0.4% over 20 days.
• ... plus another 1 alerts

Boston Scientific Corp - 5 alerts

• Overbought - The 5 day RSI is +74.2. (Bearish)
• Oversold - The 5 month RSI is +22.5. (Bullish)
• Cross Over (Up):20dma . (Bullish) This alert has occurred 15 times over the last last year. The average forward returns are -0.8% over 5 days, 0.7% over 10 days, 1.2% over 15 days and 2.0% over 20 days.
• ... plus another 2 alerts

Thermo Fisher Scientific Inc - 4 alerts

• Overbought - The 5 week RSI is +72.5. (Bearish)
• Overbought - The 15 week RSI is +70.4. (Bearish)
• Overbought - The 5 month RSI is +75.2. (Bearish)
• ... plus another 1 alerts

Pfizer Inc - 3 alerts

• Price is at a 9d low. (Bearish)
• Oversold - The 5 day RSI is +8.5. (Bullish)
• 5d RSI Oversold. (Bearish) This alert has occurred 66 times over the last last year. The average forward returns are -0.1% over 5 days, -0.6% over 10 days, 0.3% over 15 days and -0.4% over 20 days.
• ... plus another 0 alerts

Stryker Corp - 1 alert

• Volatility Squeeze:BB Width Narrowing (st). (Bullish) This alert has occurred 50 times over the last last year. The average forward returns are -0.3% over 5 days, -1.2% over 10 days, -0.8% over 15 days and 0.1% over 20 days.

Danaher Corp - 1 alert

• Volatility Squeeze:BB Width Narrowing (lt). (Bullish) This alert has occurred 11 times over the last last year. The average forward returns are -2.3% over 5 days, -4.7% over 10 days, -7.1% over 15 days and -9.0% over 20 days.

WELL Health Technologies Corp - 4 alerts

• Oversold - The 5 day RSI is +25.7. (Bullish)
• Golden Cross:50 & 200 dma. (Bullish) This alert has never occurred in recent times.
• 5d RSI Oversold. (Bearish) This alert has occurred 59 times over the last last year. The average forward returns are 0.3% over 5 days, 0.9% over 10 days, 1.8% over 15 days and 2.3% over 20 days.
• ... plus another 1 alerts

Elevance Health Inc - 1 alert

• Price is at a 6d low. (Bearish)

McKesson Corp - 14 alerts

• Price is at a 9d high. (Bullish)
• Overbought - The 5 day RSI is +95.5. (Bearish)
• Overbought - The 15 day RSI is +76.7. (Bearish)
• ... plus another 11 alerts

Cigna Group - 4 alerts

• Oversold - The 5 month RSI is +27.9. (Bullish)
• Volatility Squeeze:BB Width Narrowing (mt). (Bullish) This alert has occurred 12 times over the last last year. The average forward returns are -1.1% over 5 days, -2.9% over 10 days, -4.7% over 15 days and -7.6% over 20 days.
• Cross Over (Down):50dma . (Bearish) This alert has occurred 9 times over the last last year. The average forward returns are -2.3% over 5 days, -1.6% over 10 days, -3.5% over 15 days and -6.0% over 20 days.
• ... plus another 1 alerts

CVS Health Corp - 16 alerts

• Price is at a 5d high. (Bullish)
• Overbought - The 5 day RSI is +95.7. (Bearish)
• Overbought - The 15 day RSI is +82.1. (Bearish)
• ... plus another 13 alerts

Zoetis Inc - 4 alerts

• Oversold - The 5 week RSI is +29.2. (Bullish)
• Oversold - The 5 month RSI is +19.2. (Bullish)
• Cross Over (Down):5dma . (Bearish) This alert has occurred 41 times over the last last year. The average forward returns are -0.2% over 5 days, -0.4% over 10 days, -0.3% over 15 days and -1.3% over 20 days.
• ... plus another 1 alerts

HCA Healthcare Inc - 1 alert

• Overbought - The 5 month RSI is +81.8. (Bearish)

Cencora Inc - 14 alerts

• Overbought - The 5 day RSI is +86.1. (Bearish)
• Overbought - The 15 day RSI is +71.3. (Bearish)
• Overbought - The 5 week RSI is +86.6. (Bearish)
• ... plus another 11 alerts

Becton Dickinson and Co - 3 alerts

• Volatility Squeeze:BB Width Narrowing (mt). (Bullish) This alert has occurred 23 times over the last last year. The average forward returns are 1.6% over 5 days, 0.8% over 10 days, 0.3% over 15 days and -1.0% over 20 days.
• Cross Over (Down):20dma . (Bearish) This alert has occurred 12 times over the last last year. The average forward returns are 0.2% over 5 days, 0.3% over 10 days, 0.2% over 15 days and -0.4% over 20 days.
• Volatility Squeeze:BB Width Narrowing (st). (Bullish) This alert has occurred 57 times over the last last year. The average forward returns are 0.4% over 5 days, -0.3% over 10 days, -0.5% over 15 days and -1.0% over 20 days.
• ... plus another 0 alerts

Edwards Lifesciences Corp - 8 alerts

• Oversold - The 5 day RSI is +17.9. (Bullish)
• Oversold - The 15 day RSI is +27.0. (Bullish)
• Oversold - The 5 week RSI is +18.5. (Bullish)
• ... plus another 5 alerts

IDEXX Laboratories Inc - 6 alerts

• Overbought - The 5 day RSI is +73.5. (Bearish)
• Overbought - The 5 month RSI is +93.2. (Bearish)
• Overbought - The 15 month RSI is +77.1. (Bearish)
• ... plus another 3 alerts

Cardinal Health Inc - 3 alerts

• Overbought - The 15 month RSI is +71.6. (Bearish)
• Overbought - The 30 month RSI is +71.7. (Bearish)
• Cross Over (Up):5dma . (Bullish) This alert has occurred 27 times over the last last year. The average forward returns are 0.5% over 5 days, 0.8% over 10 days, 2.2% over 15 days and 2.4% over 20 days.
• ... plus another 0 alerts

Dexcom Inc - 2 alerts

• Oversold - The 5 week RSI is +20.5. (Bullish)
• Oversold - The 5 month RSI is +17.5. (Bullish)

... plus even more alerts for other assets!

Share    

Events - The Week Ahead

Thu Oct 16 23:04:58 UTC 2025

There are 18 events in the next 7 days.

Share    

Merck & Co Inc (Overall - Favourable)

Thu Oct 16 22:47:53 UTC 2025

US Large Caps: Merck & Co Inc has a total score of +21 and there are 4 alerts.

The overall assessment of Merck & Co Inc is favorable, based on the combination of health, valuation, price, and models ratings. The company demonstrates strong operational efficiency and profit generation, reflected in its healthy rating. The fair valuation suggests that the stock is reasonably priced, making it an attractive investment opportunity. The neutral price rating indicates stability, while the positive models rating points to potential upward movement in the stock price. Additionally, there is an upcoming earnings report scheduled for October 30, 2025, which could serve as a catalyst for movement, either expected or unexpected. This combination of factors leads to an overall favorable rating, suggesting that investors may find Merck to be a solid choice in their portfolio.

Share    

UnitedHealth Group Inc (Score +23)

Thu Oct 16 22:47:25 UTC 2025

US Large Caps: UnitedHealth Group Inc has an overall score of +23 and there is one alert.

The score is composed from the following sections:

• +13 Price
• 0 Sentiment
• +4 Fundamentals
• -2 Flow
• +8 Models

Share    

Events - Today

Thu Oct 16 21:31:32 UTC 2025

There are 2 events today.

Share    

Merck & Co Inc (Overall - Favourable)

Thu Oct 16 21:24:04 UTC 2025

US Large Caps: Merck & Co Inc has a total darwin score of +21 and there are 4 alerts.

The overall assessment of Merck & Co Inc is favorable, based on the combination of health, valuation, price, and models ratings. The company demonstrates strong operational efficiency and profit generation, reflected in its healthy rating. The fair valuation suggests that the stock is reasonably priced, making it an attractive investment opportunity. The neutral price rating indicates stability, while the positive models rating points to potential upward movement in the stock price. Additionally, there is an upcoming earnings report scheduled for October 30, 2025, which could serve as a catalyst for movement, either expected or unexpected. This combination of factors leads to an overall favorable rating, suggesting that investors may find Merck to be a solid choice in their portfolio.

Share    

UnitedHealth Group Inc (Score +23)

Thu Oct 16 21:23:38 UTC 2025

US Large Caps: UnitedHealth Group Inc has an overall score of +23 and there is one alert.

The score is composed from the following sections:

• +13 Price
• 0 Sentiment
• +4 Fundamentals
• -2 Flow
• +8 Models

Share    

Overbought Assets

Thu Oct 16 20:08:37 UTC 2025

Asset Name	RSI(10d)	Asset Score
AirSculpt Technologies Inc (AIRS)	94.3	+29
CVS Health Corp (CVS)	87.8	+24
Neogenomics Inc (NEO)	86.9	+11
Johnson & Johnson (JNJ)	85.4	+25
McKesson Corp (MCK)	83.1	+38
BioLife Solutions Inc (BLFS)	81.0	+22
ReShape Lifesciences Inc (RSLS)	79.8	-8
Verici DX PLC (VRCI)	79.3	-10
US Physical Therapy Inc (USPH)	76.9	+16
Privia Health Group Inc (PRVA)	76.5	+10
Klotho Neurosciences Inc (KLTO)	76.4	+15
Cencora Inc (COR)	76.3	+34
Krystal Biotech Inc (KRYS)	75.7	+6
TNF Pharmaceuticals Inc (TNFA)	75.3	+9
Ensign Group Inc (ENSG)	74.5	+39
Arrowhead Pharmaceuticals Inc (ARWR)	73.6	+21
Abivax SA American Depositary Shares (ABVX)	73.4	+34
Arcus Biosciences Inc (RCUS)	72.3	-1
Hims & Hers Health Inc (HIMS)	71.9	+48
Incyte Corp (INCY)	71.8	+11
Gilead Sciences Inc (GILD)	71.2	+20
Quest Diagnostics Inc (DGX)	70.7	+34
Catalyst Pharmaceuticals Inc (CPRX)	70.5	+50

Share    

UnitedHealth Group Inc (Score +23)

Thu Oct 16 19:55:57 UTC 2025

US Large Caps: UnitedHealth Group Inc has a total score of +23 and there is one alert.

The score is composed from the following sections:

• +13 Price
• 0 Sentiment
• +4 Fundamentals
• -2 Flow
• +8 Models

Share    

Oversold Assets

Thu Oct 16 18:44:17 UTC 2025

Asset Name	RSI(10d)	Asset Score
Carisma Therapeutics Inc (CARM)	8.0	-29
Organon & Co (OGN)	16.9	-7
Amphastar Pharmaceuticals Inc (AMPH)	17.0	-12
Cyclacel Pharmaceuticals Inc (CYCC)	20.5	-32
Elevation Oncology Inc (ELEV)	21.9	-16
Edwards Lifesciences Corp (EW)	22.7	-8
Verde Science Inc (VRCI)	23.7	-4
CorVel Corp (CRVL)	24.7	-4
Incannex Healthcare Ltd ADR (IXHL)	25.2	-12
Owens & Minor Inc (OMI)	25.6	-18
Henry Schein Inc (HSIC)	26.6	+1
Synaptogenix Inc (SNPX)	26.7	-13
Pfizer Inc (PFE)	27.2	-1
Principal Technologies Inc (PTEC)	27.6	+16
Marvel Biosciences Corp (MRVL)	28.1	+18
Revelation Biosciences Inc (REVB)	28.8	-28
STAAR Surgical Co (STAA)	29.3	-22

Share    

UnitedHealth Group Inc (Score +23)

Thu Oct 16 18:42:54 UTC 2025

US Large Caps: UnitedHealth Group Inc has an overall score of +23 and there is one alert.

The score is composed from the following sections:

• +13 Price
• 0 Sentiment
• +4 Fundamentals
• -2 Flow
• +8 Models

Share    

Laggards by 1 Day Performance

Thu Oct 16 17:37:23 UTC 2025

Asset Name	Perf(1d)%	Asset Score
PMGC Holdings Inc (ELAB)	-17.6	+9
Synaptogenix Inc (SNPX)	-11.1	-13
NuCana PLC (NCNA)	-8.4	-27
Windtree Therapeutics Inc (WINT)	-6.3	-12
Cyclacel Pharmaceuticals Inc (CYCC)	-6.0	-32
STAAR Surgical Co (STAA)	-4.8	-22
Marvel Biosciences Corp (MRVL)	-4.4	+18
Owens & Minor Inc (OMI)	-3.9	-18
Medicus Pharma Ltd (MDCX)	-3.8	+12
Cooper Companies Inc (COO)	-3.4	+1
Vericel Corp (VCEL)	-3.0	-3
Amphastar Pharmaceuticals Inc (AMPH)	-3.0	-12
Cigna Group (CI)	-2.5	-9
Abbott Laboratories (ABT)	-2.4	+11
Abivax SA American Depositary Shares (ABVX)	-2.3	+34
Catheter Precision Inc (VTAK)	-2.2	-23
Elevation Oncology Inc (ELEV)	-2.1	-16
Healthcare Triangle Inc (HCTI)	-2.1	-14
UFP Technologies Inc (UFPT)	-2.0	+1
WELL Health Technologies Corp (WELL)	-1.9	+22
Insulet Corp (PODD)	-1.8	+8
Centene Corp (CNC)	-1.8	+14
Healthequity Inc (HQY)	-1.6	+17
GlucoTrack Inc (GCTK)	-1.5	-14
Prestige Consumer Healthcare Inc (PBH)	-1.5	-5
Molina Healthcare Inc (MOH)	-1.3	+7
Dexcom Inc (DXCM)	-1.2	-8
Integra Lifesciences Holdings Corp (IART)	-1.2	-13
Biogen Inc (BIIB)	-1.1	-13
Humacyte Inc (HUMA)	-1.1	-11
Vertex Pharmaceuticals Inc (VRTX)	-1.0	+3
Align Technology Inc (ALGN)	-1.0	-16
Mesa Laboratories Inc (MLAB)	-1.0	+14
Zoetis Inc (ZTS)	-0.9	0
Penumbra Inc (PEN)	-0.9	-10
ICU Medical Inc (ICUI)	-0.9	-18
Becton Dickinson and Co (BDX)	-0.8	+1
AMN Healthcare Services Inc (AMN)	-0.8	+2
IQVIA Holdings Inc (IQV)	-0.8	+29
Harmony Biosciences Holdings Inc (HRMY)	-0.8	+5
Merck & Co Inc (MRK)	-0.7	+21
Teleflex Inc (TFX)	-0.7	+1
Edwards Lifesciences Corp (EW)	-0.6	-8
Premier Inc (PINC)	-0.6	+16
AbbVie Inc (ABBV)	-0.6	+16
Pfizer Inc (PFE)	-0.5	-1
Medpace Holdings Inc (MEDP)	-0.5	+16

Share    

UnitedHealth Group Inc (Score +23)

Thu Oct 16 17:34:06 UTC 2025

US Large Caps: UnitedHealth Group Inc has an overall darwin score of +23 and there is one alert.

The score is composed from the following sections:

• +13 Price
• 0 Sentiment
• +4 Fundamentals
• -2 Flow
• +8 Models

Share    

Leaders by 1 Day Performance

Thu Oct 16 16:27:14 UTC 2025

Asset Name	Perf(1d)%	Asset Score
TNF Pharmaceuticals Inc (TNFA)	48.1	+9
ReShape Lifesciences Inc (RSLS)	22.5	-8
Hims & Hers Health Inc (HIMS)	16.2	+48
Xencor Inc (XNCR)	13.4	+6
Helius Medical Technologies Inc (HSDT)	11.9	-19
agilon health inc (AGL)	11.5	-19
Black Diamond Therapeutics Inc (BDTX)	10.4	+26
Replimune Group Inc (REPL)	9.0	-9
Arcus Biosciences Inc (RCUS)	8.2	-1
AirSculpt Technologies Inc (AIRS)	8.1	+29
ACADIA Pharmaceuticals Inc (ACAD)	6.8	+35
Klotho Neurosciences Inc (KLTO)	6.6	+15
Corcept Therapeutics Inc (CORT)	6.5	+29
Neogenomics Inc (NEO)	6.3	+11
Arrowhead Pharmaceuticals Inc (ARWR)	6.2	+21
Vir Biotechnology Inc (VIR)	6.1	+3
Schrodinger Inc (SDGR)	6.1	+7
Emergent BioSolutions Inc (EBS)	5.6	+22
Moderna Inc (MRNA)	5.6	-1
MacroGenics Inc (MGNX)	5.0	-2
Azenta Inc (AZTA)	4.7	+14
Catalyst Pharmaceuticals Inc (CPRX)	4.7	+50
QuidelOrtho Corp (QDEL)	4.4	-11
Innoviva Inc (INVA)	4.3	+9
RadNet Inc (RDNT)	4.0	+34
BioLife Solutions Inc (BLFS)	3.9	+22
Myriad Genetics Inc (MYGN)	3.8	-3
Bioventus Inc (BVS)	3.7	+17
Pacira Biosciences Inc (PCRX)	3.2	-6
Co-Diagnostics Inc (CODX)	3.1	-3
Carisma Therapeutics Inc (CARM)	2.9	-29
Vaxart Inc (VXRT)	2.9	-15
Avanos Medical Inc (AVNS)	2.9	-15
Astrana Health Inc (ASTH)	2.8	+16
TG Therapeutics Inc (TGTX)	2.7	+21
DENTSPLY SIRONA Inc (XRAY)	2.6	-7
Krystal Biotech Inc (KRYS)	2.6	+6
Embecta Corp (EMBC)	2.6	+13
Tandem Diabetes Care Inc (TNDM)	2.6	-3
Incyte Corp (INCY)	2.5	+11
Tempus AI Inc (TEM)	2.3	+7
Pediatrix Medical Group Inc (MD)	2.2	+11
Simulations Plus Inc (SLP)	2.2	+2
Collegium Pharmaceutical Inc (COLL)	2.2	+17
Illumina Inc (ILMN)	2.2	-7
Adapthealth Corp (AHCO)	1.8	+22
Eli Lilly and Co (LLY)	1.8	+47

Share    

UnitedHealth Group Inc (Score +23)

Thu Oct 16 16:23:25 UTC 2025

US Large Caps: UnitedHealth Group Inc has an overall score of +23 and there is one alert.

The score is composed from the following sections:

• +13 Price
• 0 Sentiment
• +4 Fundamentals
• -2 Flow
• +8 Models

Share    

Relative Scores

Thu Oct 16 15:16:47 UTC 2025

The average score across these 189 assets is 8.0.

Share    

UnitedHealth Group Inc (Score +23)

Thu Oct 16 15:13:01 UTC 2025

US Large Caps: UnitedHealth Group Inc has an overall score of +23 and there is one alert.

The score is composed from the following sections:

• +13 Price
• 0 Sentiment
• +4 Fundamentals
• -2 Flow
• +8 Models

Share    

Candle Patterns (Price Sentiment)

Thu Oct 16 13:50:34 UTC 2025

Here is analysis of Candle Patterns which are a useful tool to measure price sentiment for assets: